Chinese pharmaceutical company Harbin Gloria Pharmaceuticals intends to issue medium-term notes due 2019 in a public offering to raise CNY1.6bn ($243.13m).
F. Hoffmann-La Roche (Roche) and Warp Drive Bio have formed a partnership to deploy the latter’s genome mining platform to develop antibiotics for bacterial infections.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Warp Drive Bio will receive an upfront payment of $87m and up to $300m in milestone payments for sales on products licensed to Roche
Roche is a Switzerland-based pharmaceutical company, while Warp Drive Bio is a drug discovery company based in the US.
US-based biotechnology company Intrexon plans to raise $100m through the private placement of one million series A redeemable preferred stock priced at $100 a share.
Opiant Pharmaceuticals plans to raise $150m through a public offering of common stock and warrants.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe US-based pharmaceutical company plans to use the funds for general corporate purposes.
Lipocine plans to issue shares of its common stock in a public offering to raise $25m.
The US-based pharmaceutical firm plans to use the funds towards general corporate purposes.
